The High Authority for Health (HAS) was contacted by the Ministry of Solidarity and Health to develop a recommendation for good practice relating to transidentity. After those devoted to the care of adults, the HAS begins work relating to minors.
Its recommendations aim to clarify and structure the support and type of care offered to minors questioning their gender or transgender identity as well as the support of those around them.
The population considered concerns minors questioning their gender identity or transgender people. In France, majority is obtained at the age of 18, unless emancipated.
Expected benefits
-Fprovide clear and appropriate informationfor minors and their entourage, on the issues and modalities of this transition journey.
–Propose treatments and support adapted to the minor’s situationits puberty stage and its transition level.
–Avoid medical wandering minors in the transition process and reduce the risk of self-medication.
– Harmonize professional practices.
Priority recipients of HAS production
-Professionals: all professionals likely to care for minors questioning their gender identity or transgender, and in particular: pediatricians, general practitioners, endocrinologists, psychiatrists, child psychiatrists, psychologists, fertility doctors, school doctors, social workers.
-Institutional: Ministry of Health and National Health Insurance Fund.
– Users: minors wondering about their gender or transgender identity, as well as their loved ones.
– Others: user and community health associations.
Question(s) to be addressed
Firstly, the following will be documented: the sociological and ethical context, the available epidemiological data; the regulations in force concerning minors (minors’ rights, consent,
medical confidentiality, role of the legal representative, etc.);
The list of questions and points to be addressed is as follows:
– What are the definitions to remember?
– What support can be offered to minors and those around them when faced with questions about gender transition depending on the puberty stage? : What information should be sent to them?; Which professionals or multi-professional teams should they be directed towards?
– What care is provided for a minor wishing to enter a transition course? : What reasonable and proportionate reflection period should be proposed depending on the care? ; What therapeutic strategy should be proposed depending on the pubertal stage? (Puberty blockers: at what stage of puberty? what molecules? what follow-up? Hormone therapy: at what stage of puberty? what choice of treatment? what follow-up? Is there a place for surgery? And, if so: in what case and at what stage should surgery be considered, and which one?) What other treatments should we offer? Speech therapy, general health care, including mental health, etc.
– What support can be offered to the minor and those around them during their journey, and in particular the transition between pediatric and adult monitoring teams?
– What support and care when faced with a desire to stop transition or detransition?
The place of digital health in the organization of support and care, as well as the environmental issues linked to care and their organizations will be addressed.
Provisional production calendar
‒ Date of passage in committee: January 27, 2026
‒ College validation date: February 25, 2026
‒ Literature review: 1st semester 2026
‒ Steering group meetings: 2nd half of 2026
‒ Meeting(s) of the rating group: 2nd half of 2026
‒ Drafting of the text of the recommendations: 1st half of 2027
‒ Request from the reading group: 1st semester 2027
‒ Plenary meeting of the steering and rating group: 1st half of 2027
‒ Validation by authorities: 2nd half of 2027
Transidentity: support for minors and their entourage, and care offered – Framework note
